Julie K Bower1,2, Sejal Patel1, Joyce E Rudy1, Ashley S Felix1. 1. Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH. 2. Division of Cardiovascular Medicine, The Ohio State University College of Medicine, Columbus, OH.
Abstract
PURPOSE OF REVIEW: Use of the electronic health record (EHR) for CVD surveillance is increasingly common. However, these data can introduce systematic error that influences the internal and external validity of study findings. We reviewed recent literature on EHR-based studies of CVD risk to summarize the most common types of bias that arise. Subsequently, we recommend strategies informed by work from others as well as our own to reduce the impact of these biases in future research. RECENT FINDINGS: Systematic error, or bias, is a concern in all observational research including EHR-based studies of CVD risk surveillance. Patients captured in an EHR system may not be representative of the general population, due to issues such as informed presence bias, perceptions about the healthcare system that influence entry, and access to health services. Further, the EHR may contain inaccurate information or be missing key data points of interest due to loss to follow-up or over-diagnosis bias. Several strategies, including implementation of unique patient identifiers, adoption of standardized rules for inclusion/exclusion criteria, statistical procedures for data harmonization and analysis, and incorporation of patient-reported data have been used to reduce the impact of these biases. SUMMARY: EHR data provide an opportunity to monitor and characterize CVD risk in populations. However, understanding the biases that arise from EHR datasets is instrumental in planning epidemiological studies and interpreting study findings. Strategies to reduce the impact of bias in the context of EHR data can increase the quality and utility of these data.
PURPOSE OF REVIEW: Use of the electronic health record (EHR) for CVD surveillance is increasingly common. However, these data can introduce systematic error that influences the internal and external validity of study findings. We reviewed recent literature on EHR-based studies of CVD risk to summarize the most common types of bias that arise. Subsequently, we recommend strategies informed by work from others as well as our own to reduce the impact of these biases in future research. RECENT FINDINGS: Systematic error, or bias, is a concern in all observational research including EHR-based studies of CVD risk surveillance. Patients captured in an EHR system may not be representative of the general population, due to issues such as informed presence bias, perceptions about the healthcare system that influence entry, and access to health services. Further, the EHR may contain inaccurate information or be missing key data points of interest due to loss to follow-up or over-diagnosis bias. Several strategies, including implementation of unique patient identifiers, adoption of standardized rules for inclusion/exclusion criteria, statistical procedures for data harmonization and analysis, and incorporation of patient-reported data have been used to reduce the impact of these biases. SUMMARY: EHR data provide an opportunity to monitor and characterize CVD risk in populations. However, understanding the biases that arise from EHR datasets is instrumental in planning epidemiological studies and interpreting study findings. Strategies to reduce the impact of bias in the context of EHR data can increase the quality and utility of these data.
Entities:
Keywords:
bias; cardiovascular disease; electronic health record; epidemiology; risk factors
Authors: Allison Stolte; M Giovanna Merli; Jillian H Hurst; Yaxing Liu; Charles T Wood; Benjamin A Goldstein Journal: Soc Sci Med Date: 2022-01-29 Impact factor: 4.634
Authors: Nick Townsend; Denis Kazakiewicz; F Lucy Wright; Adam Timmis; Radu Huculeci; Aleksandra Torbica; Chris P Gale; Stephan Achenbach; Franz Weidinger; Panos Vardas Journal: Nat Rev Cardiol Date: 2021-09-08 Impact factor: 32.419
Authors: Jarrod E Dalton; Elizabeth R Pfoh; Neal V Dawson; Lyla Mourany; Alissa Becerril; Douglas D Gunzler; Kristen A Berg; Douglas Einstadter; Nikolas I Krieger; Adam T Perzynski Journal: Med Decis Making Date: 2022-11 Impact factor: 2.749
Authors: Iona Cheng; Scarlett L Gomez; Mindy C DeRouen; Caroline A Thompson; Alison J Canchola; Anqi Jin; Sixiang Nie; Carmen Wong; Jennifer Jain; Daphne Y Lichtensztajn; Yuqing Li; Laura Allen; Manali I Patel; Yihe G Daida; Harold S Luft; Salma Shariff-Marco; Peggy Reynolds; Heather A Wakelee; Su-Ying Liang; Beth E Waitzfelder Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-05-17 Impact factor: 4.254
Authors: Jeannette M Beasley; Joyce C Ho; Sarah Conderino; Lorna E Thorpe; Megha Shah; Unjali P Gujral; Jennifer Zanowiak; Nadia Islam Journal: Diabetol Metab Syndr Date: 2021-12-18 Impact factor: 5.395
Authors: Louis Dron; Vinusha Kalatharan; Alind Gupta; Jonas Haggstrom; Nevine Zariffa; Andrew D Morris; Paul Arora; Jay Park Journal: Lancet Digit Health Date: 2022-10